Although, as mentioned above, glycemic control with long-term CSII use has been extensively studied in the literature (1–9), only one pediatric study has retrospectively assessed insulin needs at CSII initiation without reporting in detail rates of hypoglycemia and hyperglycemia (18). This evidence concerns the gene INS and Hyperglycemia.